Annual General Meeting
The Annual General Meeting of Evotec SE will take place on Wednesday, 19 June 2019, at 10.00 am (CEST), at the business premises of Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg (Directions - in German only).
Agenda
- Presentation of the approved annual financial statements and the consolidated financial statements of Evotec AG as of 31 December 2018, as approved by the Supervisory Board, the management reports for Evotec AG and the Group for fiscal year 2018, the report of the Supervisory Board and the comments by the Management Board regarding this information pursuant to §§ 289a para 1, 315a para 1 of the German Commercial Code (Handelsgesetzbuch, HGB).
- Resolution regarding formal approval of the actions of the members of the Management Board for fiscal year 2018.
- Resolution regarding formal approval of the actions of the members of the Supervisory Board for fiscal year 2018.
- Resolution regarding the appointment of the auditor for the annual financial statements and the consolidated financial statements for fiscal year 2019.
- Resolution regarding the election of a new Supervisory Board.
- Resolution regarding amendments to the Remuneration of Supervisory Board members and to the Articles of Association.
- Resolution revoking the existing authorisation to issue convertible bonds and/or warrant-linked bonds, participation rights and/or income bonds (or combinations of those instruments), revoking the corresponding contingent capital and new resolution authorising the issuance of convertible bonds and/or warrant-linked bonds, participation rights and/or income bonds (or combinations of those instruments), creation of new contingent capital, and amendments to the Articles of Association.
- Resolution regarding the approval of the remuneration system for members of the Management Board of Evotec SE.
Other documents
Downloads
Annual Report 2018 (including Consolidated financial statements, the Management report for the Group for fiscal year 2018, information pursuant to §§ 289a para 1, 315a para 1 of the German Commercial Code and explanatory report and the report of the Supervisory Board)PDF, 2.7 MB
Evotec AG Financial Statements and Management Report 2018 PDF, 1.4 MB
Explanations with regard to agenda item 1 PDF, 57.1 KB
On agenda item 4: Complementary information regarding the proposed auditor PDF, 93.6 KB
On agenda item 5: Curriculum vitae Prof. Dr. Wolfgang PlischkePDF, 104.4 KB
On agenda item 5: Curriculum vitae Prof. Dr Iris Löw-FriedrichPDF, 102.8 KB
On agenda item 5: Curriculum vitae Dr Mario PolywkaPDF, 100.6 KB
On agenda item 5: Curriculum vitae Mr Roland SackersPDF, 99.7 KB
On agenda item 5: Curriculum vitae Dr Michael Shalmi (new)PDF, 59.1 KB
On agenda item 5: Curriculum vitae Dr Elaine SullivanPDF, 236.3 KB
On agenda item 8: Remuneration reportPDF, 624.1 KB
On agenda item 8: Overview of the major changes to the remuneration system from 2018 onwards PDF, 91.3 KB
Total number of shares and voting rightsPDF, 48.0 KB
Explanations of shareholder rightsPDF, 118.6 KB
Articles of AssociationPDF, 175.1 KB
Proxy
Via Internet proxy and voting instruction to the proxy named by the Company as well as general information to issue a proxy: Voting Proxy.
If you have any queries in conjunction with the issue of a proxy, contact our hotline on telephone No. +49.(0)89.889 690 620 from Monday to Friday 09.00 a.m. to 5.00 p.m. (CEST).
Counter Motions: No counter motions have been received.
Contact your AGM Team
Evotec SE
Dr Werner Lanthaler
CEO
Katja Werner
Investor Relations Associate
Manfred Eigen Campus
Essener Bogen 7
22419 Hamburg
T: +49.(0)40.5 60 81-210
F: +49.(0)40.5 60 81-333
hauptversammlung@evotec.com
Your ADR contact:
JPMorgan Chase & Co.
P.O. Box 64504
St. Paul, MN 55164-0504
USA
T: 800.990 1135 (from within the USA)
T: +1.651.453 2128 (from abroad)
jpmorgan.adr@eq-us.com
TOP